Want to see SY full AI Analyst Report?
SY Stock Chart & Stats
$2.88
$0.04(4.64%)
At close: 4:00 PM EST
$2.88
$0.04(4.64%)
Day’s Range― - ―
52-Week Range$1.28 - $6.28
Previous CloseN/A
Volume37.58K
Average Volume (3M)784.25K
Market Cap
$154.59M
Enterprise Value$1.28B
Total Cash (Recent Filing)$876.69M
Total Debt (Recent Filing)$379.00M
Price to Earnings (P/E)―
Beta0.93
Next Earnings
Aug 13, 2026EPS Estimate
-0.09Next Dividend Ex-DateN/A
Dividend Yield0.91%
Share Statistics
EPS (TTM)-1.95
Shares Outstanding84,698,240
10 Day Avg. Volume520,189
30 Day Avg. Volume784,246
Financial Highlights & Ratios
PEG Ratio0.17
Price to Book (P/B)1.52
Price to Sales (P/S)1.59
P/FCF Ratio-7.80
Enterprise Value/Market Cap8.29
Enterprise Value/Revenue0.78
Enterprise Value/Gross Profit1.69
Enterprise Value/Ebitda-6.31
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-1.6
Revenue Forecast (FY)$2.11B
Bulls Say, Bears Say
Bulls Say
Business ExpansionSoYoung Clinic has quickly expanded with 31 centers in major cities, verifying SY’s strength in differentiating brand position for quality standardized service and value-for-money mindshare for the mass public.
Cash FlowApproximately 80% of aesthetic centers generated positive operating cash flow, demonstrating proven execution for profitable store management.
ValuationA new SOTP framework better captures various SY’s business at different growth phases, with a target price of US$5.5, emphasizing the unique omni-channel advantage for light medical aesthetic services.
Bears Say
Investment RisksInvestment risks include potential price wars on key products, competitors’ subsidies, fluctuating supply chain capabilities, and increasing customer acquisition costs.
So-Young International News
SY FAQ
What was So-Young International’s price range in the past 12 months?
So-Young International lowest stock price was $1.28 and its highest was $6.28 in the past 12 months.
What is So-Young International’s market cap?
So-Young International’s market cap is $154.59M.
When is So-Young International’s upcoming earnings report date?
So-Young International’s upcoming earnings report date is Aug 13, 2026 which is in 39 days.
How were So-Young International’s earnings last quarter?
So-Young International released its earnings results on May 22, 2026. The company reported -$0.093 earnings per share for the quarter, beating the consensus estimate of -$0.107 by $0.014.
Is So-Young International overvalued?
According to Wall Street analysts So-Young International’s price is currently Overvalued.
Does So-Young International pay dividends?
So-Young International pays a Annually dividend of $0.026 which represents an annual dividend yield of 0.91%. See more information on So-Young International dividends here
What is So-Young International’s EPS estimate?
So-Young International’s EPS estimate is -0.09.
How many shares outstanding does So-Young International have?
So-Young International has 84,698,240 shares outstanding.
What happened to So-Young International’s price movement after its last earnings report?
So-Young International reported an EPS of -$0.093 in its last earnings report, beating expectations of -$0.107. Following the earnings report the stock price went down -16.479%.
Which hedge fund is a major shareholder of So-Young International?
Currently, no hedge funds are holding shares in SY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
So-Young International Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-52.25%
12-Months-Change
Fundamentals
Return on Equity
-15.90%
Trailing 12-Months
Asset Growth
5.78%
Trailing 12-Months
Company Description
So-Young International
So-Young International Inc. manages a digital platform specializing in medical aesthetics and elective healthcare services, serving customers in the People's Republic of China and globally. This online ecosystem enables users to explore content, share personal experiences regarding medical aesthetic procedures, and book in-person treatments with various medical aesthetic service providers. The platform also offers resources for researching treatment trends, features ratings and reviews of treatment experiences, and publishes blogs under headings like "Beauty Diaries." Beyond cosmetic enhancements, So-Young facilitates reservations for a broader spectrum of healthcare needs, including dermatology, dentistry (with orthodontics), ophthalmology, comprehensive physical examinations, gynecology, human papillomavirus vaccinations, and postnatal support. The company also supplies Software-as-a-Service (SaaS) solutions and provides guidance and training programs to medical service providers. Its offerings extend to internet information and technology advisory, management consulting, and internet culture services. Furthermore, So-Young is involved in the sale of medical equipment, equipment manufacturing, sales, and agency services, as well as microfinance. As of December 31, 2021, its platform had established connections with approximately 8,400 medical aesthetic service providers and an additional 5,000 providers offering other consumption-focused healthcare services. Established in 2013, So-Young International Inc. maintains its corporate headquarters in Beijing, China.
SY Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicated strong operational and top-line momentum driven by rapid expansion of the branded clinic network, substantial increases in aesthetic center revenue (+~186% YoY), improving clinic-level margins (27% gross margin, +8.4 pp YoY), rising treatment volumes and growing core membership. Management reinforced clinical, supply-chain and training investments and provided confident near-term guidance. Offsetting these positives are widened consolidated net losses, rising cost of revenue and elevated operating expenses tied to expansion, modest declines in non-clinic segments, and a slightly reduced cash balance after funding growth initiatives. On balance the substantive revenue and margin progress at the core clinic business and forward guidance materially outweigh near-term profitability and cash draws tied to scaling.View all SY earnings summariesTechnical Analysis
HealthStream
―
Health Catalyst
―
Clinigence Holdings
―
Claritev
―
Definitive Healthcare Corp
―
Ownership Overview
0.25% Insiders
0.11% Mutual Funds
4.60% Other Institutional Investors
94.92% Public Companies and
Individual Investors